Rathbones Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Rathbones Group's BIIB Position: Q1 2019 in Review
Rathbones Group sold out of Biogen (BIIB) in Q1 2019, closing a stake of 3,708 shares — an estimated $1.12M sold.
Rathbones Group first reported a position in BIIB in Q2 2013 and held it in 22 quarters. The position peaked at $19.4M in Q4 2017. 1,084 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.
- Rathbones Group reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
- Rathbones Group sold 3,708 Biogen shares in Q1 2019, an estimated $1.12M.
- Rathbones Group first reported a position in Biogen in Q2 2013 and held it in 22 quarters.
- Rathbones Group's Biogen position peaked at $19.4M in Q4 2017.
- 1,084 funds tracked by Wall St. Rank held Biogen as of Q1 2019.
Based on Rathbones Group's 13F filing for Q1 2019, filed 9 May 2019.